A plasma N-acetyl amino acid panel for type 2 diabetes discrimination built by targeted LC–MS/MS: A case–control study - Top-Institutions - MDSpire

A plasma N-acetyl amino acid panel for type 2 diabetes discrimination built by targeted LC–MS/MS: A case–control study

  • By

  • Shusi Ding

  • Zhanxiong Xie

  • Daqiu Chen

  • Xiaomai Huang

  • Qiutong Wu

  • Lemin Zheng

  • Shanghua Xu

  • Shunxiang Luo

  • June 3, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Nanping First Hospital Affiliated to Fujian Medical University
    Nanping First Hospital Affiliated to Fujian Medical University

    Nanping, Fujian

    Key Differentiators

    • Endocrinology

  • #2

    Type 1 Diabetes TrialNet
    Type 1 Diabetes TrialNet

    Multiple Locations, N/A

    Key Differentiators

    • Endocrinology

  • #3

    Multi-Ethnic Study of Atherosclerosis
    Multi-Ethnic Study of Atherosclerosis

    Multiple Locations, N/A

    Key Differentiators

    • Endocrinology

Original Source(s)

A plasma N-acetyl amino acid panel for type 2 diabetes discrimination built by targeted LC–MS/MS: A case–control study

  • by Shusi Ding, Zhanxiong Xie, Daqiu Chen, Xiaomai Huang, Qiutong Wu, Lemin Zheng, Shanghua Xu, Shunxiang Luo

  • June 3, 2026

Related Content

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

  • May 27, 2026

  • 3 min
New Strategies for Managing Diabetic Retinopathy

AI system shows high accuracy for diabetic retinopathy screening

"AI could help reduce the burden on ophthalmology services by triaging large numbers of patients with diabetes and allowing specialists to focus on those who most urgently need care."